+86 15517541011
Author:Kangdi 03-06-2026
Pre-shipment inspection (PSI) is the most important quality control checkpoint for transdermal patch importers and brand owners. A properly executed PSI catches 80-90% of potential quality issues before products leave the factory, preventing the costly consequences of customer complaints, returns, regulatory holds, and brand reputation damage. The most common defects in transdermal patch shipments are adhesive failure (15-25% of first-time orders), incorrect ingredient labeling (10-15%), packaging defects (10-20%), and shelf life dating errors (5-10%). This guide walks you through 12 critical inspection points that every patch brand owner should verify before approving a shipment for export.
1. Why Pre-Shipment Inspection Matters
Transdermal patches are consumer products that come into direct contact with skin, often for extended wear periods. A defect that escapes detection at the factory can result in skin reactions, product ineffectiveness, regulatory violations, and customer safety incidents — all of which carry significant financial and reputational consequences. The cost of a properly executed pre-shipment inspection (typically USD 300 to USD 800 for a 1-2 day on-site inspection) is trivial compared to the cost of a single product recall, which can range from USD 50,000 to USD 500,000+ depending on the market and product distribution.
2. When to Conduct Pre-Shipment Inspection
Pre-shipment inspection should be conducted when 80% of the production batch is complete and 20% remains in packaging. This timing allows the inspector to evaluate both the bulk product and the finished packaged goods. The inspection must occur before the final container loading, so that any detected defects can be addressed or the shipment can be rejected without penalty.
For first-time orders, an additional in-production inspection (DUPRO — During Production) is recommended at the 30-50% production completion stage. The DUPRO identifies issues early enough for the manufacturer to correct them, reducing the risk of major defects appearing in the final inspection.
3. The 12 Critical Inspection Points
The following 12 inspection points cover the most common quality issues in transdermal patch shipments. Each point should be evaluated against your product specification, regulatory requirements, and brand standards.
Inspection Point 1: Adhesive Performance Test
Adhesive failure is the most common defect in transdermal patch shipments. The inspection should verify that the patch adheres immediately on application, maintains adhesion for the full wear period (typically 4-12 hours depending on product type), does not leave adhesive residue on skin after removal, and does not lift at the edges during normal movement. The test should be performed on at least 10 patches from different production batches.
Inspection Point 2: Active Ingredient Content Assay
For patches with active ingredients (menthol, camphor, lidocaine, capsaicin, methyl salicylate), the active ingredient content must be within ±10% of the labeled concentration. The assay requires HPLC or GC testing — the manufacturer should provide a Certificate of Analysis (COA) for each production batch, and the inspector should verify the COA against the production records.
Inspection Point 3: Patch Dimensions and Weight
Patch dimensions and weight must match the product specification within ±5% tolerance. Variation in dimensions can affect adhesion, comfort, and packaging fit. The inspector should measure 20-30 patches from different production batches and verify the variation is within acceptable limits.
Inspection Point 4: Visual Appearance and Color
The patch should be uniform in color, free from visible particles, and consistent with the approved sample. Discoloration, dark spots, or color variation between patches indicates formulation instability or contamination. Heat patches should show uniform iron powder distribution when the patch is opened.
Inspection Point 5: Backing Material Integrity
The backing material should be free from holes, tears, wrinkles, and delamination. The release liner should peel cleanly without tearing or leaving residue. Any backing defect compromises the patch's barrier function and shelf life.
Inspection Point 6: Sealing and Packaging Integrity
Each individual pouch should be properly sealed with no open seals, weak seals, or visible gaps. A simple seal strength test (pull the seal by hand) can identify weak seals. The inspector should test 30-50 pouches from different production batches.
Inspection Point 7: Label Content and Accuracy
Every label element must be verified against the approved artwork: product name, active ingredients, warnings, directions for use, batch number, manufacturing date, expiration date, manufacturer name and address, country of origin, and required regulatory marks (FDA registration, CE mark, etc.). Labeling errors are one of the most common causes of regulatory holds at US Customs.
Inspection Point 8: Batch Number and Date Coding
Batch numbers and date codes should be present, legible, and consistent across all packaging levels (individual pouches, inner boxes, master cartons). The expiration date should be calculated correctly based on the manufacturing date and the product's certified shelf life.
Inspection Point 9: Master Carton and Shipping Packaging
Master cartons should be of the specified dimensions, properly labeled, and structurally sound. The inner packaging should protect the product during transit — typically with adequate dunnage and orientation labels. Any visible damage to master cartons should trigger a deeper inspection of inner contents.
Inspection Point 10: Quantity Verification
The inspector should verify the actual quantity against the order quantity. A 2-3% shortage is normal due to production overruns and sampling, but larger shortages indicate production or packaging issues. The quantity should be verified by counting the master cartons and randomly opening cartons to verify inner quantities.
Inspection Point 11: Microbial Testing (if applicable)
For patches with natural ingredients, water-based formulations, or those used on broken or sensitive skin, microbial testing is required. The total aerobic microbial count should be below 100 CFU/g and the test for specific organisms (E. coli, Staphylococcus aureus, Pseudomonas aeruginosa) should be negative. The COA should verify microbial limits.
Inspection Point 12: Storage and Container Conditions
Before container loading, the inspector should verify the storage area is clean, dry, temperature-controlled, and free from pests. The container should be inspected for cleanliness, dryness, odor, and structural integrity. The loading process should follow proper protocols to prevent damage during transit.
4. AQL Sampling Standards for Patch Inspection
Acceptable Quality Level (AQL) sampling is the standard for patch inspection. For most patch shipments, the recommended AQL is 1.0 for critical defects (defects that could cause safety issues or regulatory failure), 2.5 for major defects (defects that could cause customer complaints or returns), and 4.0 for minor defects (cosmetic issues that do not affect function). The sample size is determined by the lot size and AQL level, with most patch shipments using a sample of 32-125 units depending on lot size.
5. The Inspection Report and Decision
After completing the inspection, the inspector prepares a detailed report with photographs, measurements, test results, and a pass/fail decision. The report should be reviewed by the brand owner before approving shipment. If defects are found, the report should include a clear description, photographs, and recommended corrective action (rework, re-inspection, or rejection). The brand owner should not approve shipment until all critical and major defects are addressed.
6. Working with a Manufacturer That Supports Inspection
The best manufacturers welcome third-party inspections and provide full access to production records, COAs, and quality documentation. At Kangdi Medical, our quality assurance team supports customer inspections at all stages — during production, pre-shipment, and during container loading. We provide full documentation packages including batch COAs, stability data, and production records. Our 37-year operational history and ISO 13485 certification ensure that our production processes consistently meet the quality standards required by brand owners and regulatory authorities.
7. Build a Reliable Quality Control Process
Pre-shipment inspection is one component of a comprehensive quality control process. A complete quality system includes raw material inspection, in-process quality checks, finished product testing, stability monitoring, and post-market surveillance. For first-time patch brand owners, working with an experienced manufacturer is the most effective way to ensure product quality without building an internal quality infrastructure from scratch.
Contact Kangdi Medical to discuss your quality requirements, inspection protocols, and how our quality assurance team can support your supply chain. We provide detailed quality documentation, welcome third-party inspections, and work with brand owners to develop product-specific quality standards.
Email: hnkangdi888@hotmail.com
WhatsApp: +86 15517541011
Website: www.kangdimedical.com